Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype‐4 recurrence post–liver transplantation: A prospective cohort trial

Author:

El‐Hamamsy Manal1,Montasser Iman Fawzy2,Mansy Azza El‐Sayed3,Nabet Dina Ezzeldin4ORCID,El‐Meteini Mahmoud5

Affiliation:

1. Clinical Pharmacy, Faculty of Pharmacy King Abdulaziz University Jeddah Saudi Arabia

2. Tropical Medicine, Faculty of Medicine, Ain Shams Centre for Organ Transplantation (ASCOT) Ain Shams University Cairo Egypt

3. Clinical Pharmacy, Faculty of Pharmacy El‐Fayoum University El‐Fayoum Egypt

4. Pharmaceutical Sciences, Clinical pharmacy, Faculty of Pharmacy, Ain Shams Centre for Organ Transplantation (ASCOT), Ain Shams University Specialized Hospital Ain Shams University Cairo Egypt

5. Hepato‐Pancreato‐Biliary Surgery, Faculty of Medicine, Ain Shams Centre for Organ Transplantation (ASCOT) Ain Shams University Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Efficacy of sofosbuvir plus ribavirin with or without peginterferon‐alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection. Infectious Disorders‐Drug;Ahmed OA;Targets,2017

3. Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real‐life clinical practice;Abd‐Elsalam S;Adv Virol,2018

4. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

5. Quality of Life and Physical Activity in Liver Transplantation Patients: Results of a Case-Control Study in Italy

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3